02.12.2021 17:31

Why Is FMC (FMC) Down 4.8% Since Last Earnings Report?

It has been about a month since the last earnings report for FMC (FMC). Shares have lost about 4.8% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is FMC due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. FMC Corp’s Earnings and Revenues Top Estimates in Q3FMC Corp. recorded earnings (as reported) of $1.22 per share in third-quarter 2021, up 44% from 85 cents reported a year ago.  Barring one-time items, adjusted earnings per share were $1.43, topping the Zacks Consensus Estimate of $1.30. Revenues were $1,194 million for the quarter, up around 10% from the year-ago quarter. It surpassed the Zacks Consensus Estimate of $1,166.4 million.Revenues were driven by a 9% rise in volumes and 1% favorable impact of currencies. The company benefited from strong product demand, its focus on increasing prices and cost discipline amid headwinds from supply-chain and logistics issues in the reported quarter.Regional Sales PerformanceSales dropped 6% year over year in North America in the quarter, impacted by a shift in volume by geography from the company’s global diamide partnerships.Sales in Latin America went up 11% year over year in the reported quarter on soybean and corn growth in Brazil and Argentina as well as higher prices.In EMEA, sales rose 12% year over year on higher demand for diamides and herbicides in the region.Revenues climbed 20% year over year in Asia on the back of broad-based volume gains and higher prices across nearly all countries.FinancialsThe company had cash and cash equivalents of $341 million at the end of the quarter, up roughly 15% year over year. Long-term debt was $2,631.7 million, down around 13% year over year.The company repurchased shares worth $200 million in the third quarter.GuidanceFor 2021, FMC continues to expect revenues between $4.9 billion and $5.1 billion, indicating a rise of 8% at the midpoint versus 2020.The company also reaffirmed its adjusted EBITDA guidance in the band of $1.29-$1.35 billion for 2021, indicating a 6% rise at the midpoint versus 2020.FMC raised its adjusted earnings per share outlook for 2021 to the range of $6.59-$6.99 from $6.54-$6.94 expected earlier, suggesting an increase of 10% at the midpoint compared with 2020.Free cash flow for 2021 is projected to be $480-$570 million, indicating a 4% year-over-year decline.The company also expects to buyback $350-$450 million shares in 2021.For fourth-quarter 2021, revenues are projected in the band of $1.27-$1.47 billion, reflecting an increase of 19% at the midpoint compared with the prior-year quarter. Adjusted earnings are forecast in the range of $1.80-$2.20 per share, representing an increase of 41% at the midpoint compared with the prior-year quarter.How Have Estimates Been Moving Since Then?In the past month, investors have witnessed an upward trend in estimates revision.VGM ScoresCurrently, FMC has a nice Growth Score of B, though it is lagging a bit on the Momentum Score front with a C. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, FMC has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.Infrastructure Stock Boom to Sweep America A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.The only question is “Will you get into the right stocks early when their growth potential is greatest?”Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.Download FREE: How to Profit from Trillions on Spending for Infrastructure >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report FMC Corporation (FMC): Free Stock Analysis Report To read this article on Zacks.com click here.
Weiter zum vollständigen Artikel bei "Zacks"
Ausgewählte Hebelprodukte auf FMC Corp.
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Produkte auf FMC Corp.
Hebel wählen:
Quelle: Zacks

Nachrichten zu Fresenius Medical Care AG & Co. KGaA (FMC) St.

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Fresenius Medical Care AG & Co. KGaA (FMC) St.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
17.01.2022Fresenius Medical Care UnderweightJP Morgan Chase & Co.
12.01.2022Fresenius Medical Care UnderweightJP Morgan Chase & Co.
10.01.2022Fresenius Medical Care HoldKepler Cheuvreux
05.01.2022Fresenius Medical Care UnderweightJP Morgan Chase & Co.
04.01.2022Fresenius Medical Care UnderweightJP Morgan Chase & Co.
01.12.2021Fresenius Medical Care BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
05.11.2021Fresenius Medical Care KaufenDZ BANK
05.11.2021Fresenius Medical Care KaufenNorddeutsche Landesbank (Nord/LB)
05.11.2021Fresenius Medical Care BuyUBS AG
04.11.2021Fresenius Medical Care BuyGoldman Sachs Group Inc.
10.01.2022Fresenius Medical Care HoldKepler Cheuvreux
01.12.2021Fresenius Medical Care HoldDeutsche Bank AG
01.12.2021Fresenius Medical Care HoldJefferies & Company Inc.
11.11.2021Fresenius Medical Care HoldJefferies & Company Inc.
03.11.2021Fresenius Medical Care NeutralCredit Suisse Group
17.01.2022Fresenius Medical Care UnderweightJP Morgan Chase & Co.
12.01.2022Fresenius Medical Care UnderweightJP Morgan Chase & Co.
05.01.2022Fresenius Medical Care UnderweightJP Morgan Chase & Co.
04.01.2022Fresenius Medical Care UnderweightJP Morgan Chase & Co.
17.11.2021Fresenius Medical Care UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care AG & Co. KGaA (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Börse Stuttgart Anlegerclub

Heute im Fokus

Zinsangst & Ukraine-Konflikt: DAX schließt tiefrot -- US-Börsen unter Druck -- Accell von KKR übernommen -- Infineon sieht 2023 Ende der Chipkrise -- Evergrande, Lufthansa, Commerzbank, TUI im Fokus

Schaeffler stärkt mit Übername Robotikgeschäft. Boeing investiert 450 Millionen Dollar in Lufttaxi-Start-up Wisk. Gorillas will französischen Essenslieferdienst Frichti übernehmen. Bundesnetzagentur erwägt Verzicht auf Mobilfunk-Auktion. Hedgefonds Trian Partners will anscheinend mit Unilever-Beteiligung Druck machen.


Halten Sie es für richtig, dass die EZB an ihrer lockeren Geldpolitik festhält?

finanzen.net zero
finanzen.net zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln